NEW YORK ( TheStreet) -- Shares of Transition Therapeutics (Nasdaq: TTHI) were gapping up Monday morning with an open price 25.7% higher than Friday's closing price. The stock closed at $4.01 Friday and opened today's trading at $5.04. The average volume for Transition has been 141,900 shares per day over the past 30 days. Transition has a market cap of $95.2 million and is part of the health care sector and drugs industry. Shares are up 106.7% year to date as of the close of trading on Friday. Transition Therapeutics Inc., a biopharmaceutical company, develops novel therapeutics for various disease indications primarily in Canada. TheStreet Ratings rates Transition as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full Transition Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
More from Markets
Dow Futures, Nike, Boeing, Juul and Facebook - 5 Things You Must Know
U.S. stock futures rise after U.S. Treasury Secretary Steven Mnuchin confirms that trade talks between the U.S. and China would resume the week of Oct. 7; Nike reports earnings; Boeing to pay crash victims' families $144,500 each; Facebook buys CTRL-labs.
FAA: No Timetable for Return of 737 Max in Meeting With Regulators
Air safety officials from around the globe gather to hear update on grounded Boeing jet.
Economic Perspective: Can Negative Rates Stimulate Growth?
Should the Federal Reserve follow the ECB down the path of negative rates?